CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 2,493 · Q1 • database Scopus / SJR & Web of Science indexed
Molecular Cancer Therapeutics
United States · American Association for Can...
workspace_premium Q1 — Oncology lock Subscription

Molecular Cancer Therapeutics

Molecular Cancer Therapeutics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 206. It has a price of 3000 €. It has an SJR impact factor of 2,493 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,493.

Molecular Cancer Therapeutics focuses its scope in these topics and keywords: inhibitor, cancer, potent, protein, cells, resistance, activity, vitro, inhibition, kinase, ...

Publisher: American Association for Cancer Research Inc.
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
2,493 Q1
H-index 206
Acceptance rate pie_chart
20% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.000 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,493

H-index

206

Docs (year)

149

Docs 3y

518

Total refs

7085

Cites 3y

2980

Citable 3y

510

Cites/Doc 2y

4.96

Ref/Doc

47.55

Immediate OA

3000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Molecular Cancer Therapeutics?

Molecular Cancer Therapeutics has an SJR of 2,493 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 3000 EUR. Non-OA / submission fee is 0 EUR.

What is the acceptance rate?

The acceptance rate recorded for Molecular Cancer Therapeutics is 20%.